AlgoTherapeutix announces results of its phase 2 “ACT” trial of ATX01 in chemotherapy-induced peripheral neuropathy: Paris, France Wednesday, February 19, 2025, 13:00 Hrs [IST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback